Skip to content
Business
Prognosis

Adderall Shortages Spread to Four Pharma Companies

  • Prescriptions for the ADHD drug have risen in recent years
  • Companies’ production of Adderall is limited by federal rules
30mg tablets of Adderall XR

30mg tablets of Adderall XR

Photographer: JB Reed/Bloomberg

Corrected

Four pharmaceutical companies had generic extended-release Adderall on backorder in August at a time of unprecedented demand for the attention-deficit/hyperactivity disorder drug.

Amneal Pharmaceuticals Inc., Rhodes Pharmaceuticals LP (a subsidiary of Purdue Pharma LP), Novartis AG’s Sandoz unit, and Teva Pharmaceutical Industries Ltd. all had supply issues with some doses of generic Adderall XR, according to the University of Utah’s drug information service and emails from the companies to the university staff provided to Bloomberg News. Some doses were expected to become available at the end of August and others in September.